New York City, NY -- (SBWIRE) -- 12/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: Real Goods Solar, Inc. (NASDAQ:RSOL), Aastrom Biosciences Inc (NASDAQ:ASTM), Tower Group International, Ltd. (NASDAQ:TWGP), Amarin Corporation plc (ADR) (NASDAQ:AMRN)
Real Goods Solar, Inc. (NASDAQ:RSOL) added 1.57% recently, while trading on 444,943 shares at the price of $2.58. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.41 and was moved to its maximum level of $7.17.The stock changed hands in a range of $2.51 to $2.60, bringing its market capitalization at about $77.99 million. Real Goods Solar, Inc. is a solar energy company serving the commercial, residential and utility customers. As of February 5, 2013, the Company had installed more than 14,500 solar power systems representing over 100 megawatts of 100% renewable energy.
Will RSOL Continue To Move Higher? Find Out Here
Aastrom Biosciences Inc (NASDAQ:ASTM) declined -8.94% recently, in the current trading session, at $3.96 with a total volume of 161,284 shares. The stock, on average, trades on a volume of 132,742 shares. In the past 52 weeks, the share price has not declined below $3.16 and above $29.80.It floated in a range of $3.72 to $4.04 during the recent trading session, with a beta value of 0.79.Its market capitalization now moved to about $17.35 million. Aastrom Biosciences, Inc. (Aastrom) is a development-stage company. The Company is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. The Company is developing patient-specific, expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases.
Why Should Investors Buy ASTM After the Recent Fall? Just Go Here and Find Out
Tower Group International, Ltd. (NASDAQ:TWGP) declined -1.93% and was moving within a range of $4.05-$4.28. Its current trading price is $4.08. The share price hit its 52-week low of $3.53 and $22.30 was the best price. The stock completed the day with a total volume of 525,702 shares, versus an average volume of 2.18 million shares.
Will TWGP Get Buyers Even After The Recent Rally? Find Out Here
Amarin Corporation plc (ADR) (NASDAQ:AMRN) added 3.30% in its current trading activity, bringing its market capitalization around $324.49 million. The total number of shares that changed hands during the current session up till now was 2.91 shares, as compared to average trading volume of 7.92 million shares. The share price after opening at $1.89 made a high of $1.97 and hovered above $1.85, while its recent trading price was $1.87. Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company’s product candidate is AMR101, an ultra-pure omega-3 fatty acid. It is developing AMR101 for the treatment of patients with high triglyceride levels, or hypertriglyceridemia. In September 2011, it filed a New Drug Application (NDA), with the United States Food and Drug Administration (FDA). In December 2011, it commenced patient dosing in its cardiovascular outcomes study of AMR101, titled REDUCE-IT (Reduction of Cardiovascular Events with eicosapentanoic acid (EPA) - Intervention Trial).
Why Should Investors Buy AMRN After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)